Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease (original) (raw)

References

  1. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, Maeda K, Shibata R, Walsh K, Funahashi T, Shimomura I (2006) Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47:1108–1116
    CAS PubMed Google Scholar
  2. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384–1389
    CAS PubMed PubMed Central Google Scholar
  3. Piñeiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J, Diéguez C, Gualillo O, González-Juanatey JR, Lago F (2005) Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 579:5163–5169
    PubMed Google Scholar
  4. Wang ZV, Scherer PE (2008) Adiponectin, cardiovascular function, and hypertension. Hypertension 51:8–14
    CAS PubMed Google Scholar
  5. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y (2002) Adiponectin in essential hypertension. J Nephrol 15:507–511
    CAS PubMed Google Scholar
  6. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y (2003) Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16:72–75
    CAS PubMed Google Scholar
  7. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, Ong LH, Tam S, Tan KC, Janus ED, Lam TH, Lam KS (2007) Hypoadiponectinemia as a predictor for the development of hypertension: A 5-year prospective study. Hypertension 49:1455–1461
    CAS PubMed Google Scholar
  8. Huang KC, Chen CL, Chuang LM, Ho SR, Tai TY, Yang WS (2003) Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 88:4130–4134
    CAS PubMed Google Scholar
  9. Imatoh T, Miyazaki M, Momose Y, Tanihara S, Une H (2008) Adiponectin levels associated with the development of hypertension: A prospective study. Hypertens Res 31:229–233
    CAS PubMed Google Scholar
  10. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T (2004) Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43:1318–1323
    CAS PubMed Google Scholar
  11. Sethna CB, Leonard MB, Gallagher PR, Meyers KE (2009) Serum adiponectin levels and ambulatory blood pressure monitoring in pediatric renal transplant recipients. Transplantation 88:1030–1037
    CAS PubMed Google Scholar
  12. Hong SJ, Park CG, Seo HS, Oh DJ, Ro YM (2004) Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press 13:236–242
    CAS PubMed Google Scholar
  13. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134–141
    CAS PubMed Google Scholar
  14. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D (2005) Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 20:129–134
    CAS PubMed Google Scholar
  15. Kamariski M, Biscardi M, Cestino L, Miatello R, Guntsche E, Valles PG (2009) Adiponectin in children on peritoneal dialysis: relationship to insulin resistance and nutritional status. Nephron Clin Pract 113:c24–c32
    CAS PubMed Google Scholar
  16. Wang Y, Lam KS, Yau MH, Xu A (2008) Post-translational modifications of adiponectin: Mechanisms and functional implications. Biochem J 409:623–633
    CAS PubMed Google Scholar
  17. Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, Wong C, Muñoz A, Warady BA (2006) Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1:1006–1015
    PubMed Google Scholar
  18. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am 34:571–590
    CAS Google Scholar
  19. Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE (2008) Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 149:2270–2282
    CAS PubMed PubMed Central Google Scholar
  20. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–618
    CAS PubMed Google Scholar
  21. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260
    PubMed Google Scholar
  22. Khoury PR, Mitsnefes MM, Daniels SR, Kimball TR (2009) Age-Specific Reference Intervals for Indexed Left Ventricular Mass in Children. J Am Soc Echocardiogr 22:709–714
    PubMed Google Scholar
  23. Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, Warady BA (2008) Chronic Kidney Disease in Children Study Group. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension 52:631–637
    CAS PubMed Google Scholar
  24. Schwartz GJ, Furth S, Cole SR, Warady B, Muñoz A (2006) Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children. Kidney Int 69:2070–2077
    CAS PubMed Google Scholar
  25. Hada Y, Yamauchi T, Waki H, Tsuchida A, Hara K, Yago H, Miyazaki O, Ebinuma H, Kadowaki T (2007) Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun 356:487–493
    CAS PubMed Google Scholar
  26. Nishimura R, Morimoto A, Matsudaira T, Miyashita Y, Sano H, Shirasawa T, Takahashi E, Tajima N (2007) Ratio of high-, medium-, and low-molecular weight serum adiponectin to the total adiponectin value in children. J Pediatr 151:545–547
    CAS PubMed Google Scholar
  27. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D (2005) MMKD Study Group: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 16:1091–1098
    CAS PubMed Google Scholar
  28. Mitsnefes MM, Kartal J, Khoury PR, Daniels SR (2007) Adiponectin in Children with Chronic Kidney Disease: Role of Adiposity and Kidney Dysfunction. Clin J Am Soc Neph 2:46–51
    CAS Google Scholar
  29. Martin LJ, Woo JG, Daniels SR, Goodman E, Dolan LM (2005) The relationships of adiponectin with insulin and lipids are strengthened with increasing adiposity. J Clin Endocrinol Metab 90:4255–4259
    CAS PubMed Google Scholar
  30. Yaturu S, Reddy RD, Rains J, Jain SK (2007) Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine 37:1–5
    CAS PubMed Google Scholar
  31. Chudek J, Adamczak M, Karkoszka H, Budziński G, Ignacy W, Funahashi T, Matsuzawa Y, Cierpka L, Kokot F, Wiecek A (2003) Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 35:2186–2189
    CAS PubMed Google Scholar
  32. Adamczak M, Szotowska M, Chudek J, Karkoszka H, Cierpka L, Wieçek A (2007) Plasma adiponectin concentration in patients after successful kidney transplantation–a single-center, observational study. Clin Nephrol 67:381–390
    CAS PubMed Google Scholar
  33. Halberg N, Schraw TD, Wang ZV, Kim JY, Yi J, Hamilton MP, Luby-Phelps K, Scherer PE (2009) Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 58:1961–7190
    PubMed PubMed Central Google Scholar
  34. Bouskila M, Pajvani UB, Scherer PE (2005) Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity? Int J Obes (Lond) 29(Suppl 1):S17–S23
    CAS Google Scholar
  35. Shen YY, Charlesworth JA, Kelly JJ, Loi KW, Peake PW (2007) Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant 22:171–178
    CAS PubMed Google Scholar
  36. Böttner A, Kratzsch J, Müller G, Kapellen TM, Blüher S, Keller E, Blüher M, Kiess W (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89:4053–4061
    PubMed Google Scholar
  37. Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA (2005) Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 54(9):2772–2778
    CAS PubMed Google Scholar
  38. Lee S, Bacha F, Gungor N, Arslanian SA (2006) Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care 29:51–56
    CAS PubMed Google Scholar
  39. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimbürger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, Barany P, Lindholm B, Nordfors L (2004) Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 65:274–281
    CAS PubMed Google Scholar
  40. Norata GD, Baragetti I, Raselli S, Stucchi A, Garlaschelli K, Vettoretti S, Piloni G, Buccianti G, Catapano AL (2010) Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status. Nutr Metab Cardiovasc Dis 20:56–e63
    CAS PubMed Google Scholar
  41. Leth H, Andersen KK, Frystyk J, Tarnow L, Rossing P, Parving H-H, Flyvbjerg A (2008) Elevated Levels of High-Molecular-Weight Adiponectin in Type 1 Diabetes. J Clin Endocrinol Metab 93:3186–3191
    CAS PubMed Google Scholar
  42. Park SH, Carrero JJ, Lindholm B, Stenvinkel P (2009) Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin. Clin Nephrol 72:87–96
    CAS PubMed Google Scholar
  43. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, Davis KE, Bikman BT, Halberg N, Rutkowski JM, Wade MR, Tenorio VM, Kuo MS, Brozinick JT, Zhang BB, Birnbaum MJ, Summers SA, Scherer PE (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17:55–63
    CAS PubMed Google Scholar

Download references